Overview
The goal is to gain insight in the development and course of the toxicity after a curative treatment of prostate cancer
Description
All with curative intent treated prostate cancer patients will be enrolled in the SFP (Standard Follow-up Programme). It also includes the post -operative adjuvant treatments and the patients with positive lymph nodes.
Patients will complete weekly questionnaires to score the patient -rated toxicity. Biweekly patients are seen by the treating radiation oncologist and / or AIOS in which the physician -rated toxicity is scored. In the follow-up will always patient -rated toxicity and physician -rated toxicity can be determined.
Use of an SFP should yield a profit for the practitioner , such as the automatic generation of letters. This should apply to all SFPs .
Quality of life and toxicity in patients will be completed on the touch-screen computers at FU visits.
Eligibility
Inclusion Criteria:
- All curative treated patients with prostatecancer( with positive lymph nodes)
- All patients who will be treated with RT( including post-operative, adjuvant treatments)
- Are willing to fill in toxicity and QOL-questionnarys (QLQ-PR25 en de QLQ-C30)
Exclusion Criteria:
Patients who are not willing to fill in toxicity and QOL-questionnarys Patients who will
not get RT Non-curative or palliative treated patients (with bone mestasis) Non-prostate
cancer-patients